The path to potential approval for bluebird bio’s lovo-cel has become slightly smoother as the FDA has confirmed it will not be holding an advisory committee meeting before making a decision on the ...
As an FDA decision draws closer on bluebird bio’s sickle cell disease gene therapy, the company has lined up a potential sale of a priority review voucher (PRV). The agreement, worth $103 million, ...
Two voice actors are leading a class-action lawsuit against AI voiceover company Lovo for using recordings of them to create a bot that replicates their voices — and competes with them for work. Paul ...
Voice Actors Can Make Thousands of Dollars Simply by Submitting a 15-Minute Voice Sample BERKELEY, CA / ACCESSWIRE / June 2, 2021 / LOVO, an AI voice-over platform for education, marketing, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback